spacer
home > ict > Spring 2006
PUBLICATIONS

International Clinical Trials

ict
Spring 2006
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT
   
Text
PDF
Pam Barnacal introduces the inaugural ICT in her Editor’s Letter

 
download pdf
bullet
TRIAL MANAGEMENT
Emma-Kate Yates at Fast4Wd Ogilvy addresses the thorny issue of recruitment and enrolment for clinical trials in oncology, in Patients Are a Virtue  
download pdf
Taking the UK as their case study, Diana Anderson and Beth Harper at D Anderson & Company demystify the regulations involved in patient recruitment, in Going Through Customs  
download pdf
In A CRO’s Progress, ICT talks to Nigel Page, President of i3 Research, about how a business with therapeutic specialisation in mind can stay on top in a tough market  
download pdf
bullet
eCLINICAL
With ever-spiralling costs relating to the development of drug candidates,Valarie Higgins, Ellen Shea and Eva R Miller at Biostatistics, affiliated with Interactive Clinical Technologies, Inc, see promise in Intelligent Design  
download pdf
Electronic data collection, though by no means a new technology, is now beginning to demonstrate its full potential. Khaled El Emam, Chief Scientist at TrialStat Corporation, maps out this Industrial Evolution  
download pdf
Since electronic data capture systems noticeably speed up clinical data collection, David Fishbach at Phase Forward is moved to ask, Does EDC Herald the End of CTMS?  
download pdf
Mark Wheeldon at Formedix Ltd argues that EDC requires a vendor-neutral, platform-independent utility, in his article on CDISC: Eliminating Standard Deviation  
download pdf
bullet
IT & LOGISTICS
In Reading the Signals, Judy Hanover and Alison Hodges at Lincoln Technologies consider the various strategies devised to combat safety concerns in the industry – concentrating on the twin elements of signal detection and data mining  
download pdf
A high-performing supply chain is currently an industry hot topic, since it is critical in accelerating clinical development. Kunal Khattar at InfoPro Solutions, Inc, reports on Supply In Demand  
download pdf
bullet
CLINICAL THERAPEUTICS
In Curing Cancer: A New Technique Makes its Mark, Dr Lee Schacter at MDS Pharma Services talks about intelligent anticancer treatment, and its fast-growing status as the most promising method of tackling this destructive disease  
download pdf
The beauty of industry-conducted patient registries are that they benefit the public and the industry. Jean Siebenaler at Kendle shows us the Best of Both Worlds  
download pdf
bullet
MARKETPLACE
As a region at various stages of industrialisation and development, Latin America shows some promise. Dr Faiz Kermani of Chiltern International explains Clinical Research – Latino Style, showing how the pharmaceutical industry can help to drive overall improvements in the area  
download pdf
For the pharmaceutical industry, complying with European regulations can cause Legal Landmines and Operational Headaches. Arianna Greco and Fabio Marazzi of M+BIOLAW offer some pain relief  
download pdf
With widespread adoption of the electronic Common Technical Document imminent, Jim Nichols at Thomson Scientific, Liquent Regulatory Solutions Division, previews the advantages it will offer, in eCTD: No Longer Submission Impossible  
download pdf
bullet
PREVIEW
Now in its 42nd year, the DIA Annual Meeting Update offers, as always, an unmissable symposium for global pharma  
download pdf
bullet
INFORMATION
 
 
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

- The biotech companies 3P Biopharmaceuticals and Toleranzia collaborate for that MG treatment - MG is an orphan disease which has a major unmet medical need and a large market potential - The drug candidate,TOL2, has already achieved several positive preclinical results
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement